Literature DB >> 8588040

[Computerized procedures in 3-dimensional radiotherapy planning].

A Höss1, J Debus, R Bendl, R Engenhart-Cabillic, W Schlegel.   

Abstract

UNLABELLED: The aim of 3D radiotherapy treatment planning is to match the dose as closely as possible to the target volume, thus avoiding side effects in healthy tissue and radiosensitive organs at risk. A virtual radiotherapy simulator designed for the definition of treatment parameters and the analysis of precalculated dose distributions enables iterative optimization of treatment plans.
METHODS: VOXELPLAN is a software package for 3D radiotherapy treatment planning developed at the German Cancer Research Center; it consists of user interfaces for image segmentation, virtual therapy simulation, dose calculation, plan evaluation and patient documentation. It is written in C and FORTRAN and runs on VAXstation 4000, IBM RS/6000 and DEC ALPHA hardware.
RESULTS: Since 1990 a pilot installation of VOXELPLAN has been applied in clinical routine at the Center and at the University Clinic for Radiology, Heidelberg. Treatment for more than 1500 patients has been planned and carried out using the system, proving its technical and organizational applicability.
CONCLUSIONS: We expect better acceptance and further dissemination of the techniques described, conformation therapy as well as (after its technical realization) inverse planning, from continuous optimization of the planning process.

Entities:  

Mesh:

Year:  1995        PMID: 8588040

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  6 in total

1.  Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.

Authors:  S E Combs; R Ahmadi; D Schulz-Ertner; C Thilmann; J Debus
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

2.  Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme.

Authors:  S E Combs; S Gutwein; Ch Thilmann; P Huber; J Debus; D Schulz-Ertner
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

3.  New multileaf collimator with a leaf width of 5 mm improves plan quality compared to 10 mm in step-and-shoot IMRT of HNC using integrated boost procedure.

Authors:  Felix Zwicker; Henrik Hauswald; Simeon Nill; Bernhard Rhein; Christian Thieke; Falk Roeder; Carmen Timke; Angelika Zabel-du Bois; Jürgen Debus; Peter E Huber
Journal:  Strahlenther Onkol       Date:  2010-05-21       Impact factor: 3.621

4.  Results of three-dimensional stereotactically-guided radiotherapy in recurrent medulloblastoma.

Authors:  Stefanie Milker-Zabel; Angelika Zabel; Christoph Thilmann; Ivan Zuna; Angelika Hoess; Michael Wannenmacher; Jürgen Debus
Journal:  J Neurooncol       Date:  2002-12       Impact factor: 4.130

5.  Fractionated stereotactic radiation therapy in the management of primary optic nerve sheath meningiomas.

Authors:  Stefanie Milker-Zabel; Peter Huber; Wolfgang Schlegel; Jürgen Debus; Angelika Zabel-du Bois
Journal:  J Neurooncol       Date:  2009-04-01       Impact factor: 4.130

6.  Correction of patient positioning errors based on in-line cone beam CTs: clinical implementation and first experiences.

Authors:  Christoph Thilmann; Simeon Nill; Thomas Tücking; Angelika Höss; Bernd Hesse; Lars Dietrich; Rolf Bendl; Bernhard Rhein; Peter Häring; Christian Thieke; Uwe Oelfke; Juergen Debus; Peter Huber
Journal:  Radiat Oncol       Date:  2006-05-24       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.